Media Summary: Bob Smith, Venture Partner, OrbiMed; Chairman, Alliance for Regenerative Medicine (Moderator) Lynelle Hoch, President, Cell ... In this episode of Frost & Sullivan's Growth Podcast, we delve into the transformative world of cell and gene therapy ( Hear from Dr. Andrew Byrnes during the third installment of the BIO-ASGCT

The Strategic Biopharma Perspective Scaling Science Strategy And Success For Cgts - Detailed Analysis & Overview

Bob Smith, Venture Partner, OrbiMed; Chairman, Alliance for Regenerative Medicine (Moderator) Lynelle Hoch, President, Cell ... In this episode of Frost & Sullivan's Growth Podcast, we delve into the transformative world of cell and gene therapy ( Hear from Dr. Andrew Byrnes during the third installment of the BIO-ASGCT Patients and advocates often ask: Will gene therapy work for our condition? How do we know which gene therapy approach to ... Cell and gene therapies are transforming modern medicine, but their path to market is fast and complex. They often jump from ... In order to overcome the challenges currently facing cell and gene therapies (C>), the next generation of manufacturers must ...

Susan Desmond-Hellmann is a physician and scientist whose remarkable career has spanned clinical medicine, oncology, ... While cell and gene therapies are constantly evolving and offer a lot of promise for rare and chronic conditions, they are also ... The Alliance for Regenerative Medicine's annual Cell & Gene State of the Industry Briefing, a top-level gathering for key ... GENE THERAPY: COMMERCIALIZING A THERAPEUTIC PRODUCT This panel will discuss aspects of the commercialization ... This webinar will explore the critical steps required to successfully bring cell and gene therapies to market. Experts will discuss ... The effective implementation and integration of technological advancements in cell and gene therapy manufacturing can be ...

FEATURED TALK: FDA'S EFFORTS TO ADVANCE THE DEVELOPMENT AND APPROVAL OF CELLULAR AND GENE ... In this episode of the IDEA Collider, host Mike Rea sits down with Reagan Jarvis, Today's conversation sits at the intersection of one of the most ambitious - and most challenging - frontiers in modern medicine: ... In this video, we explore how advanced bioanalytical This is an introduction to the new Manufacturing and Commercialisation of Stem Cell a Gene Therapies MSc at UCL Biochemical ... Watch the 'Biologicals: The Fundamentals and the Future' MEDTalks, directly from GPCE Brisbane. With four experts taking the ...

Photo Gallery

The Strategic Biopharma Perspective: Scaling Science, Strategy and Success for CGTs
Cell and Gene Therapy: Scaling from Breakthrough Science to Commercial Reality
Recent CMC Guidance for Cellular and Gene Therapies: BIO-ASGCT CGT Science Series
Strategic Starting Points for CGT Research | Empowering Patients 2026
204: Mastering CRO Selection: Essential Questions for CMC Analytical Development with Daniel Galb...
SCALING NEW HEIGHTS IN CELL AND GENE THERAPY
346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine
Transforming the future of healthcare: Do cell and gene therapies hold the key?
ARM's 2021 Cell & Gene State of the Industry Briefing
Panel: Gene Therapy: Commercializing a Therapeutic Product
Commercialization Strategies for Cell and Gene Therapies
Defining Critical Quality Attributes in Cell & Gene Therapy | CGT Summit 2025
Sponsored
Sponsored
View Detailed Profile
The Strategic Biopharma Perspective: Scaling Science, Strategy and Success for CGTs

The Strategic Biopharma Perspective: Scaling Science, Strategy and Success for CGTs

Bob Smith, Venture Partner, OrbiMed; Chairman, Alliance for Regenerative Medicine (Moderator) Lynelle Hoch, President, Cell ...

Cell and Gene Therapy: Scaling from Breakthrough Science to Commercial Reality

Cell and Gene Therapy: Scaling from Breakthrough Science to Commercial Reality

In this episode of Frost & Sullivan's Growth Podcast, we delve into the transformative world of cell and gene therapy (

Sponsored
Recent CMC Guidance for Cellular and Gene Therapies: BIO-ASGCT CGT Science Series

Recent CMC Guidance for Cellular and Gene Therapies: BIO-ASGCT CGT Science Series

Hear from Dr. Andrew Byrnes during the third installment of the BIO-ASGCT

Strategic Starting Points for CGT Research | Empowering Patients 2026

Strategic Starting Points for CGT Research | Empowering Patients 2026

Patients and advocates often ask: Will gene therapy work for our condition? How do we know which gene therapy approach to ...

204: Mastering CRO Selection: Essential Questions for CMC Analytical Development with Daniel Galb...

204: Mastering CRO Selection: Essential Questions for CMC Analytical Development with Daniel Galb...

Cell and gene therapies are transforming modern medicine, but their path to market is fast and complex. They often jump from ...

Sponsored
SCALING NEW HEIGHTS IN CELL AND GENE THERAPY

SCALING NEW HEIGHTS IN CELL AND GENE THERAPY

In order to overcome the challenges currently facing cell and gene therapies (C>), the next generation of manufacturers must ...

346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine

346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine

Susan Desmond-Hellmann is a physician and scientist whose remarkable career has spanned clinical medicine, oncology, ...

Transforming the future of healthcare: Do cell and gene therapies hold the key?

Transforming the future of healthcare: Do cell and gene therapies hold the key?

While cell and gene therapies are constantly evolving and offer a lot of promise for rare and chronic conditions, they are also ...

ARM's 2021 Cell & Gene State of the Industry Briefing

ARM's 2021 Cell & Gene State of the Industry Briefing

The Alliance for Regenerative Medicine's annual Cell & Gene State of the Industry Briefing, a top-level gathering for key ...

Panel: Gene Therapy: Commercializing a Therapeutic Product

Panel: Gene Therapy: Commercializing a Therapeutic Product

GENE THERAPY: COMMERCIALIZING A THERAPEUTIC PRODUCT This panel will discuss aspects of the commercialization ...

Commercialization Strategies for Cell and Gene Therapies

Commercialization Strategies for Cell and Gene Therapies

This webinar will explore the critical steps required to successfully bring cell and gene therapies to market. Experts will discuss ...

Defining Critical Quality Attributes in Cell & Gene Therapy | CGT Summit 2025

Defining Critical Quality Attributes in Cell & Gene Therapy | CGT Summit 2025

In this in-depth session from the

ADVANCING MANUFACTURING AUTOMATION IN CELL AND GENE THERAPY - INSIGHTS FROM STRATEGIC COLLABORATIONS

ADVANCING MANUFACTURING AUTOMATION IN CELL AND GENE THERAPY - INSIGHTS FROM STRATEGIC COLLABORATIONS

The effective implementation and integration of technological advancements in cell and gene therapy manufacturing can be ...

FDA’s Efforts to Advance the Development and Approval of Cellular and Gene Therapies

FDA’s Efforts to Advance the Development and Approval of Cellular and Gene Therapies

FEATURED TALK: FDA'S EFFORTS TO ADVANCE THE DEVELOPMENT AND APPROVAL OF CELLULAR AND GENE ...

Scaling TCR-T Therapies: Reagan Jarvis on Non-Viral Gene Editing and Target Mapping

Scaling TCR-T Therapies: Reagan Jarvis on Non-Viral Gene Editing and Target Mapping

In this episode of the IDEA Collider, host Mike Rea sits down with Reagan Jarvis,

Building “Off-the-Shelf” Regenerative Cell Therapies: The Next Biotech Revolution | Brian Culley

Building “Off-the-Shelf” Regenerative Cell Therapies: The Next Biotech Revolution | Brian Culley

Today's conversation sits at the intersection of one of the most ambitious - and most challenging - frontiers in modern medicine: ...

Bioanalysis for Cell and Gene Therapies: A New Frontier

Bioanalysis for Cell and Gene Therapies: A New Frontier

In this video, we explore how advanced bioanalytical

Manufacturing & Commercialisation of Stem Cell & Gene Therapies MSc Webinar 9Jun20 Prof Qasim Rafiq

Manufacturing & Commercialisation of Stem Cell & Gene Therapies MSc Webinar 9Jun20 Prof Qasim Rafiq

This is an introduction to the new Manufacturing and Commercialisation of Stem Cell a Gene Therapies MSc at UCL Biochemical ...

GPCE MEDTalks - Biologics: The Fundamentals and the Future

GPCE MEDTalks - Biologics: The Fundamentals and the Future

Watch the 'Biologicals: The Fundamentals and the Future' MEDTalks, directly from GPCE Brisbane. With four experts taking the ...